Related Experiment Video
Updated: Feb 10, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
[Impaired kidney function in patients with atrial fibrillation: practical aspects]
A V Melekhov1, E F Dadashova1, I G Nikitin1
1Federal State Budgetary Educational Institution of Higher Education, "Pirogov Russian National Research Medical University" of the Ministry of Health of the Russian Federation.
Managing atrial fibrillation (AF) and chronic kidney disease (CKD) requires careful consideration. This study examines real-world antithrombotic strategies in patients with both conditions, comparing them to current guidelines.
Area of Science:
- Cardiology
- Nephrology
- Clinical Practice
Background:
- Atrial fibrillation (AF) and chronic kidney disease (CKD) frequently coexist.
- Management of AF in CKD patients presents unique challenges.
- Echocardiographic (EchoCG) changes may correlate with CKD severity.
Purpose of the Study:
- To evaluate practical management strategies for patients with concurrent AF and CKD.
- To compare the incidence of CKD stages in a real-world cohort with international data.
- To assess the relationship between EchoCG findings and CKD severity.
- To compare real-world antithrombotic prevention in AF/CKD patients against existing guidelines.
Main Methods:
- Analysis of authors' own patient data.
- Comparison of CKD stage incidence with international reports.
- Correlation analysis between EchoCG parameters and CKD severity.
- Retrospective review of antithrombotic therapy in clinical practice.
Main Results:
- Incidence of CKD stages in the study cohort was analyzed and compared internationally.
- Echocardiographic changes were found to be associated with the severity of chronic kidney disease.
- Real-world antithrombotic prevention strategies were evaluated against established clinical guidelines.
Conclusions:
- The study provides insights into the practical management of AF in CKD patients.
- Findings highlight the association between cardiac structure and kidney disease progression.
- Real-world antithrombotic prescribing patterns may deviate from current guidelines, necessitating further investigation.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Kidney Structure
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Quantitative Aspects of Drug-Receptor Interaction
Characteristics of Practical Op Amps
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...

